Home 5 Clinical Diagnostics Insider 5 Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

by | Jul 9, 2018 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet

From - Diagnostic Testing & Emerging Technologies For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine… . . . read more

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article